business process solutions... Learn More Accelerating client's success using Health IT and
Simplifying
Learn More
compliance...
regulatory
Creating value in today's
Learn More
healthcare ecosystem...
 ePrior Authorization’s
Real Benefits:
Reducing Frictional Costs and
Speeding Time to Therapy A comprehensive 107 page report
on present-day ePA and the future Learn More

POCP Blog

NCPDP Action Group Focused on Biologics and Biosimilars

By Brian Bamberger, Practice Lead, Life Sciences Biologics and biosimilars are starting to burst into the American market. Biosimilars are expected to quickly become mainstream in the near future because …

Recent Regulations Continue Promotion of ePrescribing

By Michael Burger, Senior Consultant The federal government continues to keep its foot on the gas to further the adoption and effectiveness of electronic prescribing (ePrescribing) through the rulemaking process.  …

Biosimilar Legislative Trend Means Big Changes for EHRs

By Connie Sinclair, Director, Regulatory Resource Center Biosimilars are starting to enter the market in the United States and are generating interest because of their significant cost-savings potential and patient …

Integrating EHRs and PDMPs: How Vendors Can Get Ahead of the Curve

By Michael Burger, Senior Consultant Prescription drug monitoring programs (PDMPs) were created in 2002 as a tool to help address the growing problems of prescription drug abuse and diversion. PDMPs …

Top 10 Trends at HIMSS16

By Tony Schueth Didn’t make it to HIMSS16 in Vegas? If you did go but couldn’t make it to all the sessions or exhibits, the Point-of-Care Partners team has saved …

Biosimilars 101: Considerations for Health IT and Other Stakeholders

By Tony Schueth Biosimilars now are being introduced in the United States and are expected to rapidly become lower-cost, mainstream treatments for a range of chronic diseases, including cancer, rheumatoid …

How Will I-STOP Affect Specialty Prescribing?

By Tony Schueth New York’s I-STOP (Internet System for Tracking Over-Prescribing Act) went into effect on March 27.  The law requires that New York physicians use electronic prescribing (ePrescribing) for …

There’s No Stopping I-STOP

By Tony Schueth As the Point-of-Care Partners (POCP) team travels the country for conferences and client engagements, we often get asked about New York’s I-STOP (Internet System for Tracking Over-Prescribing …

Extraneous ePrescription Notes: Best Addressed by the Sender

By Michael Burger, Senior Consultant A study was published recently in the JAMA (link here) titled, “Analysis of Prescribers’ Notes in Electronic Prescriptions in Ambulatory Practice.” The study found a …

Massachusetts’ New Law to Combat Opioid Deaths Could Affect EHR and Pharmacy Systems

By Connie Sinclair, Director, Regulatory Resource Center Massachusetts recently enacted comprehensive legislation to help combat opioid abuse deaths, which have reached crisis proportions in the Bay State and around the …